Biology of Blood and Marrow Transplantation
Volume 13, Issue 1 , Pages 26-30 , January 2007

Clinical Utility of Autopsy after Hematopoietic Stem Cell Transplantation

These data were presented in part at the annual meeting of the American Society of Hematology; 2005.

Received 8 August 2006 ,Accepted 12 September 2006.

References 

  1. Shojania KG, Burton EC, McDonald KM, Goldman L. Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA. 2003;289:2849–2856
  2. Allan DS, Belanger R, Busque L, et al. Maintaining high autopsy rates in a Canadian blood and marrow transplant program: preserving a diagnostic and research tool. Bone Marrow Transplant. 2005;35:781–785
  3. Xavier AC, Siqueira SA, Costa LJ, Mauad T, Nascimento Saldiva PH. Missed diagnosis in hematological patients-an autopsy study. Virchow Arch. 2005;446:225–231
  4. Al-Saidi F, Diaz-Granados N, Messner H, Herridge MS. Relationship between premortem and postmortem diagnosis in critically ill bone marrow transplantation patients. Crit Care Med. 2002;30:570–573
  5. Goldman L, Sayson R, Robbins S, Cohn LH, Bettmann M, Weisberg M. The value of the autopsy in three medical eras. N Engl J Med. 1983;308:1000–1005
  6. Diaz-Mitoma F, Leger C, Miller H, et al. Comparison of DNA amplification, mRNA amplification, and DNA hybridization techniques for detection of cytomegalovirus in bone marrow transplant recipients. J Clin Microbiol. 2003;41:5159–5166
  7. Bombi J, Cardesa A, Llebaria C, et al. Main autopsy findings in bone marrow transplant patients. Arch Pathol Lab Med. 1987;111:125–129
  8. de Medeiros BC, de Medeiros CR, Werner B, et al. Central nervous system infections following bone marrow transplantation: an autopsy report of 27 cases. J Hematother Stem Cell Res. 2000;9:535–540
  9. Chandrasekar PH, Weinmann A, Shearer C Bone Marrow Transplantation Team. Autopsy-identified infections among bone marrow transplant recipients: a clinico-pathologic study of 56 patients. Bone Marrow Transplant. 1995;16:675–681
  10. Rossetti F, Brawner DL, Bowden R, et al. Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features. Clin Infect Dis. 1995;20:801–811
  11. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood. 2001;97:1604–1610
  12. Cortez KJ, Fischer SH, Fable GA, et al. Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients. J Infect Dis. 2003;188:967–972
  13. Kaiser LP, Perrin L, Chapuis B. Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay. J Clin Microbiol. 2002;40:4251–4255
  14. Pumannova M, Roubalova K, Vitek A, Sajdova J. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation. Diagn Microbiol Infect Dis. 2006;54:115–120
  15. Ikewaki J, Ohtsuka E, Satou T, et al. Real-time PCR assays based on distinct genomic regions for cytomegalovirus reactivation following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2005;35:403–410
  16. Tanaka Y, Kanda Y, Kami M, et al. Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;30:315–319
  17. Hughes TP, Kaeda J, Branford S, et al. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med. 2003;349:1423–1432
  18. Hughes TP, Morgan GJ, Martiat P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood. 1991;77:874–878
  19. Rawstron AC, Kennedy B, Evans PA, et al. Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy. Blood. 2001;98:29–35
  20. van Burik JH, Leisenring W, Myerson D, et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis (An autopsy study of 355 patients). Medicine. 1998;77:246–254
  21. Durning S, Cation L. The educational value of autopsy in a residency training program. Arch Intern Med. 2000;160:997–999
  22. Hill RB, Anderson RE. The uses and value of autopsy in medical education as seen by pathology educators. Acad Med. 1991;66:97–100
  23. Kleiner DE, Emmert-Buck MR, Liotta LA. Necropsy as a research method in the age of molecular pathology. Lancet. 1995;346:945–948
  24. McPhee SJ, Bottles K, Lo B, Saika G, Crommie D. To redeem them from death (Reactions of family members to autopsy). Am J Med. 1986;80:665–671
  25. McPhee SJ. Maximizing the benefits of autopsy for clinicians and families (What needs to be done). Arch Pathol Lab Med. 1996;120:743–748
  26. Oppewal F, Meyboom-de Jong B. Family members’ experiences of autopsy. Fam Pract. 2001;18:304–308
  27. Rankin J, et al. Cross sectional survey of parents’ experience and views of the postmortem examination. BMJ. 2002;324:816–818

PII: S1083-8791(06)00641-0

doi: 10.1016/j.bbmt.2006.09.006

Biology of Blood and Marrow Transplantation
Volume 13, Issue 1 , Pages 26-30 , January 2007

Article Tools